The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bosutinib (BOS) for chronic phase (CP) chronic myeloid leukemia (CML) after imatinib (IMA) failure: ≥8-y update of a phase I/II study.
 
Tim H. Brümmendorf
Consulting or Advisory Role - Janssen; Merck; Novartis; Pfizer; Takeda
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Yeow Tee Goh
No Relationships to Disclose
 
Musa Yilmaz
No Relationships to Disclose
 
Rebecca B. Klisovic
Consulting or Advisory Role - Novartis; Visante
Research Funding - ARIAD; Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Simon Purcell
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Andrea Viqueira
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Carlo Gambacorti-Passerini
Honoraria - Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Pfizer